EDSA
Price:
$1.69
Market Cap:
$11.89M
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Industry
Biotechnology
IPO Date
2010-06-21
Stock Exchange
NASDAQ
Ticker
EDSA
According to Edesa Biotech, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.36. This represents a change of -37.03% compared to the average of -2.16 of the last 4 quarters.
The mean historical PE Ratio of Edesa Biotech, Inc. over the last ten years is -19.46. The current -1.36 PE Ratio has changed 598.81% with respect to the historical average. Over the past ten years (40 quarters), EDSA's PE Ratio was at its highest in in the December 2018 quarter at -0.86. The PE Ratio was at its lowest in in the September 2015 quarter at -58.08.
Average
-19.46
Median
-6.11
Minimum
-125.38
Maximum
-0.77
Discovering the peaks and valleys of Edesa Biotech, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 264.78%
Maximum Annual PE Ratio = -0.77
Minimum Annual Increase = -94.85%
Minimum Annual PE Ratio = -125.38
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -2.31 | 53.22% |
| 2023 | -1.51 | 95.67% |
| 2022 | -0.77 | -88.48% |
| 2021 | -6.68 | -38.81% |
| 2020 | -10.91 | 3.98% |
| 2019 | -10.50 | 89.45% |
| 2018 | -5.54 | 264.78% |
| 2017 | -1.52 | -94.85% |
| 2016 | -29.50 | -76.47% |
| 2015 | -125.38 | 25.38% |
The current PE Ratio of Edesa Biotech, Inc. (EDSA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.53
5-year avg
-4.43
10-year avg
-19.46
Edesa Biotech, Inc.’s PE Ratio is less than BioRestorative Therapies, Inc. (-0.90), less than Dogwood Therapeutics, Inc. (-0.31), less than Cocrystal Pharma, Inc. (-1.18), less than OSR Holdings, Inc. (-0.91), greater than Traws Pharma, Inc. (-1.51), greater than Immuron Limited (-2.77), less than Ernexa Therapeutics Inc. (-0.59), less than Evogene Ltd. (-0.54), less than Sensei Biotherapeutics, Inc. (-0.55), less than Imunon, Inc. (-0.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.90 | $9.46M | |
| -0.31 | $11.73M | |
| -1.18 | $10.61M | |
| -0.91 | $17.76M | |
| -1.51 | $11.25M | |
| -2.77 | $8.88M | |
| -0.59 | $10.28M | |
| -0.54 | $9.59M | |
| -0.55 | $13.32M | |
| -0.00 | $10.08M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Edesa Biotech, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Edesa Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Edesa Biotech, Inc.'s PE Ratio?
How is the PE Ratio calculated for Edesa Biotech, Inc. (EDSA)?
What is the highest PE Ratio for Edesa Biotech, Inc. (EDSA)?
What is the 3-year average PE Ratio for Edesa Biotech, Inc. (EDSA)?
What is the 5-year average PE Ratio for Edesa Biotech, Inc. (EDSA)?
How does the current PE Ratio for Edesa Biotech, Inc. (EDSA) compare to its historical average?